These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9637713)

  • 21. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
    Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
    Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.
    Ljubuncic P; Fuhrman B; Oiknine J; Aviram M; Bomzon A
    Gut; 1996 Sep; 39(3):475-8. PubMed ID: 8949657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.
    Qiao L; Studer E; Leach K; McKinstry R; Gupta S; Decker R; Kukreja R; Valerie K; Nagarkatti P; El Deiry W; Molkentin J; Schmidt-Ullrich R; Fisher PB; Grant S; Hylemon PB; Dent P
    Mol Biol Cell; 2001 Sep; 12(9):2629-45. PubMed ID: 11553704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
    Utanohara S; Tsuji M; Momma S; Morio Y; Oguchi K
    Toxicology; 2005 Oct; 214(1-2):77-86. PubMed ID: 16023280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
    Ji WJ; Qu Q; Jin Y; Zhao L; He XD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
    Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
    J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity.
    Powell AA; Akare S; Qi W; Herzer P; Jean-Louis S; Feldman RA; Martinez JD
    BMC Cancer; 2006 Sep; 6():219. PubMed ID: 16948850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
    Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of mitochondria in the differential action of sodium deoxycholate and ursodeoxycholic acid on rat duodenum.
    Pérez A; Rivoira MA; Rodríguez V; Marchionatti A; Tolosa de Talamoni N
    Can J Physiol Pharmacol; 2021 Mar; 99(3):270-277. PubMed ID: 32687730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
    van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
    Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition.
    Rodrigues CM; Stieers CL; Keene CD; Ma X; Kren BT; Low WC; Steer CJ
    J Neurochem; 2000 Dec; 75(6):2368-79. PubMed ID: 11080188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
    Lim SC; Duong HQ; Parajuli KR; Han SI
    Oncol Rep; 2012 Oct; 28(4):1429-34. PubMed ID: 22824956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding.
    Kren BT; Rodrigues CM; Setchell KD; Steer CJ
    Liver Transpl; 2001 Apr; 7(4):321-34. PubMed ID: 11303292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
    Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
    Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
    Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
    BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
    Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
    World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
    Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
    Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells.
    Liang TJ; Yuan JH; Tan YR; Ren WH; Han GQ; Zhang J; Wang LC; Qin CY
    Chin Med J (Engl); 2009 May; 122(10):1209-13. PubMed ID: 19493473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
    Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.